-
The following questions and answers provide information about the clinical trial questions most frequently asked by patients.
-
Brinker F. Oregon grape root extract for psoriasis. Altern Med Alert 2003;6(6):69-72.
-
O'Mathuna DP. The placebo affect and alternative therapies. Altern Med Alert 2003;6(6):61-69.
-
-
The Women's Health Initiatives (WHI) was halted 1 year ago, but fallout from this landmark study continues. The study was designed to identify the risks or benefits of estrogen plus progesterone vs placebo in healthy postmenopausal women.
-
-
Developing a research survey instrument is a lengthy and complicated process, says Daniel P. Sulmasy, OFM, MD, PhD, of the John J. Conley Department of Ethics at Saint Vincents Hospital in Manhattan. Sulmasy and several colleagues spent five years developing an instrument that elicits ratings of quality and satisfaction with care from medical inpatients, especially those near the end of life.
-
In 1936 Selye noted that rats exposed to stressors had enlarged adrenal glands. In the late 1940s, Kendall and Reichstein isolated cortisone as the active principle of the adrenal glands. In more recent years our understanding of the hypothalamic-pituitary-axis has grown immensely.
-
The combined infusion of AVP and NE was superior to NE alone in catecholamine-resistant vasodilatory shock.
-
Cardiac resynchronization therapy improves quality of life and New York Heart Association Functional class in patients with moderate-to-severe heart failure, wide QRS durations, and indications for an ICD.